<DOC>
	<DOCNO>NCT01056263</DOCNO>
	<brief_summary>The primary objective observational study retrospectively collect current survival data patient originally include axitinib A4061012 [ NCT00076011 ] study estimate 5-year survival rate subject metastatic renal cancer cell treat axitinib .</brief_summary>
	<brief_title>Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012</brief_title>
	<detailed_description>Subjects participate observational study originally participate study A4061012 [ NCT00076011 ] , may also participate study A4061008 [ NCT00828919 ] . Subjects participate observational study originally participate study A4061012 [ NCT00076011 ] , may also participate study A4061008 [ NCT00828919 ] . 5-year survival information update .</detailed_description>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Subjects participate observational study originally participate study A4061012 [ NCT00076011 ] may also participate study A4061008 [ NCT00828919 ] Subjects withdraw original study A4061012 [ NCT00076011 ] continue access study A4061008 [ NCT00828919 ]</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>retrospective trial</keyword>
	<keyword>5-year survival</keyword>
	<keyword>metastatic renal cancer cell</keyword>
</DOC>